Macbecins I and II, new antitumor antibiotics. II. Isolation and characterization. (Q34285976)
scientific article
Language:
Current Data About Macbecins I and II, new antitumor antibiotics. II. Isolation and characterization.
(P31) (Q13442814)
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P304) 205-212
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P433) 2
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P478) 33
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P577) +1980-00-00T00:00:00Z
(P248)
(P813) Friday, September 16, 2022

(P921) (Q12187)

(Q135175)
(P3452)

(Q77502068)
(P3452)

(P953) https://www.jstage.jst.go.jp/article/antibiotics1968/33/2/33_2_205/_pdf
(P248)
(P813) Tuesday, March 19, 2024
(P854) https://api.unpaywall.org/v2/10.7164/antibiotics.33.205?email=unpaywall_01@example.com

(P1433) (Q7743552)
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P1476) "Macbecins I and II, new antitumor antibiotics. II. Isolation and characterization" (language: en)
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P2093) M Muroi
(P1545) 1
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

M Izawa
(P1545) 2
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

Y Kosai
(P1545) 3
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

M Asai
(P1545) 4
(P248)
(P698) 7380730
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7380730%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P2860) (Q28327610)
(P248)
(P813) Friday, April 12, 2024
(P854) https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.255

(Q34285971)
(P248)
(P813) Friday, April 12, 2024
(P854) https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.33.205

(Q45194224)
(P248)
(P813) Friday, April 12, 2024
(P854) https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.33.205

(P6954) (Q232932)
(P248)
(P813) Tuesday, March 19, 2024
(P854) https://api.unpaywall.org/v2/10.7164/antibiotics.33.205?email=unpaywall_01@example.com

(P7228) (Q232932)
(P887)

other details
description scientific article

External Links
(P356) 10.7164/ANTIBIOTICS.33.205
(P698) 7380730